Mirum Pharmaceuticals Inc (+1, MIRM US, September 14th)
Patrick Heron (Director since Nov. 2018) purchased $257,000 worth of stock on September 12th at $30.44. The purchase is indirect Frazier Life Sciences Healthcare, a private equity and venture capital firm where Heron has been a GP since 1999. Heron/Frazier Life, spent $3.9 million two weeks ago on a secondary offering at $26.25, and it is interesting to see them add at a higher price, in their first open market purchase in these shares.
The company named a new CFO, Eric Bjerkholt, in September and he made his first purchase, spending $300,000. He was formerly the CFO at Chinook Therapeutics. This is the first insider buying since November 2021 when the stock was at $14.
We are ranking the stock +1.